The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 9,301–9,400 of 31,469
Preclinical changes in the mechanical properties of abdominal aorta in obese children
Iannuzzi, A., Licenziati, M. R., Acampora, C., Salvatore, V., Marco, D. D., Mayer, M. C., Michele, M. D., & Russo, V. (2004) · Metabolism · doi:10.1016/j.metabol.2004.03.023 · Cited by 39
Jürimäe, J., Jürimäe, T., Ring‐Dimitriou, S., LeMura, L. M., Arciero, P. J., & von DUVILLARD, S. P. (2009) · Metabolism · doi:10.1016/j.metabol.2008.12.009 · Cited by 39
Ukkola, O. H., & Kesäniemi, Y. A. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602621 · Cited by 39
Burgdorf, K. S., Gjesing, A. P., Grarup, N., Justesen, J. M., Sandholt, C. H., Witte, D. R., Jørgensen, T., Madsbad, S., Hansen, T. F., & Pedersen, O. B. (2011) · Diabetologia · doi:10.1007/s00125-011-2320-4 · Cited by 39
Metabolic Syndrome Affects Fatty Acid Composition of Plasma Lipids in Obese Prepubertal Children
Gil‐Campos, M., Ramírez-Tortosa, M. C., Larqué, E., Linde, J., Aguilera, C. M., Cañete, R., & Gil, Á. (2008) · Lipids · doi:10.1007/s11745-008-3203-4 · Cited by 40
Wada, H., Satoh, N., Kitaoka, S., Ono, K., Morimoto, T., Kawamura, T., Nakano, T., Fujita, M., Kita, T., Shimatsu, A., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.045 · Cited by 39
Colao, A., Somma, C. D., Spiezia, S., Rota, F., Pivonello, R., Savastano, S., & Lombardi, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2566 · Cited by 38
Śledziński, T., Śledziński, M., Smolenski, R. T., & Świerczyński, J. (2009) · Obesity Surgery · doi:10.1007/s11695-009-0041-2 · Cited by 39
Lee, H., Lee, J., Hwang, S.-S., Kim, S., Chin, H. J., Han, J. S., & Heo, N. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055106 · Cited by 39
Risk Factors for Liver Steatosis in Obese Children and Adolescents
Lin, Y., Chang, P., Yeh, S.-J., et al. (2010) · Pediatrics & Neonatology · doi:10.1016/s1875-9572(10)60028-9 · Cited by 39
Vos, R. C., Wit, J. M., Pijl, H., & Houdijk, E. C. A. M. (2011) · Nutrition and Diabetes · doi:10.1038/nutd.2011.5 · Cited by 39
Chan, D. C., Watts, G. F., Barrett, P. H. R., O’Neill, F. H., & Thompson, G. R. (2003) · Obesity Research · doi:10.1038/oby.2003.83 · Cited by 39
Adiponectin and Risk of New-Onset Diabetes Mellitus After Kidney Transplantation
Bayés, B., Lauzurica, R., Granada, M. L., Serra, A., Bonet, J., Fontseré, N., Salinas, I., & Romero, R. (2004) · Transplantation · doi:10.1097/01.tp.0000132561.48217.b1 · Cited by 39
Effects of metformin on the body composition in subjects with risk factors for type 2 diabetes
Rodríguez‐Moctezuma, J. R., Robles‐López, G., López-Carmona, J. M., & Gutiérrez‐Rosas, M. J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00385.x · Cited by 40
Kawamoto, R., Kohara, K., Tabara, Y., Abe, M., Kusunoki, T., & Miki, T. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.2584 · Cited by 39
Manco, M., Alisi, A., Real, J.-M. F., Equitani, F., Vito, R. D., Valenti, L. V. C., & Nobili, V. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.007 · Cited by 39
Ashry, F. E. Z. Z. E., Mahmoud, M. F., Maraghy, N. N. E., & Ahmed, A. F. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.12.020 · Cited by 39
Central Obesity, the Metabolic Syndrome, and Plasminogen Activator Inhibitor‐1 in Young Adults
Appel, S. J., Harrell, J. S., & Davenport, M. L. (2005) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2005.00083.x · Cited by 39
Vitamin D insufficiency in obese children and relation with lipid profile
Rusconi, R. E., Cosmi, V. D., Ghilardi, G., Giavoli, C., & Agostoni, C. V. (2015) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2014.959902 · Cited by 39
Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis
Panoulas, V. F., Douglas, K., Milionis, H. J., et al. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002298 · Cited by 39
Elevated Ambulatory Blood Pressure in a Multi-Ethnic Population of Obese Children and Adolescents
Aguilar, A., Ostrow, V., Luca, F. D., & Suarez, E. A. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.12.028 · Cited by 41
Longitudinal evaluation of reproductive function in women treated for bipolar disorder
Rasgon, N., Reynolds-May, M. F., Elman, S., Saad, M. F., Frye, M. A., Bauer, M., & Altshuler, L. L. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.002 · Cited by 39
Been, L. F., Nath, S. K., Ralhan, S. K., Wander, G. S., Mehra, N. K., Singh, J., Mulvihill, J. J., & Sanghera, D. K. (2009) · Obesity · doi:10.1038/oby.2009.254 · Cited by 39
Han, S., Zhang, H., Qin, L., & Zhai, C. (2013) · Nutrients · doi:10.3390/nu5020552 · Cited by 39
Ribbing, J., Hamrén, B., Svensson, M. K. E., & Karlsson, M. O. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009349711 · Cited by 39
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia
Derosa, G., Maffioli, P., D’Angelo, A., SALVADEO, S. A. T., Ferrari, I., Fogari, E., Gravina, A., Mereu, R., Palumbo, I., Randazzo, S., et al. (2009) · Clinical and investigative medicine · doi:10.25011/cim.v32i2.6030 · Cited by 39
Tsekouras, Y. E., Amalia, Y. E., Bougatsas, D., Kavouras, S. A., & Sidossis, L. S. (2007) · Metabolism · doi:10.1016/j.metabol.2007.03.012 · Cited by 39
Major components of metabolic syndrome and adiponectin levels: a cross-sectional study
von Frankenberg, A. D., do Nascimento, F. V., Gatelli, L. E., Nedel, B. L., Garcia, S. P., de Oliveira, C. S., Saddi-Rosa, P., Reis, A. F., Canani, L. H. S., & Gerchman, F. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-26 · Cited by 39
Samara-Boustani, D., Colmenares, A., Elie, C., Dabbas, M., Beltrand, J., Caron, V., Ricour, C., Jacquin, P., Tubiana-Rufi, N., Levy-Marchal, C., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0670 · Cited by 37
Larsen, M. O., Juhl, C. B., Pørksen, N. K., Gotfredsen, C. F., Carr, R. D., Ribel, U., Wilken, M., & Rolin, B. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00352.2004 · Cited by 39
Rietman, A., Schwarz, J., Blokker, B., Siebelink, E., Kok, F. J., Afman, L. A., Tomé, D., & Mensink, M. (2014) · Journal of Nutrition · doi:10.3945/jn.114.191072 · Cited by 39
Torun, E., Gönüllü, E., Özgen, İ. T., Cindemir, E., & Öktem, F. (2013) · International Journal of Endocrinology · doi:10.1155/2013/631845 · Cited by 39
HIV is an independent predictor of aortic stiffness
Rider, O. J., Asaad, M., Ntusi, N., Wainwright, E., Clutton, G., Hancock, G., Banerjee, R., Pitcher, A., Samaras, K., Clarke, K., et al. (2014) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-014-0057-1 · Cited by 40
Prevalence and lifestyle determinants of the metabolic syndrome.
Villegas, R., Creagh, D., Hinchion, R., O’Halloran, D., & Perry, I. J. (2004) · PubMed · Cited by 39
Identifying Children at Risk for Obesity, Type 2 Diabetes, and Cardiovascular Disease
Velasquez‐Mieyer, P., Perez-Faustinelli, S., & Cowan, P. A. (2005) · Diabetes Spectrum · doi:10.2337/diaspect.18.4.213 · Cited by 40
Halbirk, M., Nørrelund, H., Møller, N., Schmitz, O., Gøtzsche, L. B.-H., Nielsen, R. R., Nielsen‐Kudsk, J. E., Nielsen, S. S., Nielsen, T. T., Eiskjær, H., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00475.2010 · Cited by 40
Johansen, O. E., Brustad, E., Enger, S., & Tveit, A. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-28 · Cited by 40
Iglesias, P., Díez, J. J., Fernández‐Reyes, M. J., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02049.x · Cited by 39
Veena, S. R., Krishnaveni, G. V., Karat, S. C., Osmond, C., & Fall, C. H. D. (2012) · Public Health Nutrition · doi:10.1017/s1368980012003795 · Cited by 40
Goossens, G. H., Petersen, L. V., Blaak, E. E., Hul, G. B. J., Arner, P., Astrup, A. V., Froguel, P., Patel, K., Pedersen, O. B., Polak, J., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.59 · Cited by 39
Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome
Ooi, E. M. M., Barrett, P. H. R., Chan, D. C., Nestel, P. J., & Watts, G. F. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.004 · Cited by 39
de Luis, D. A., Aller, R., Romero, E., Dueñas, A., & Castrillón, J. L. P. (2010) · PubMed · Cited by 39
Lü, B., Zhao, M. H., Jiang, W., Ma, J., Yang, C., Shao, J., & Gu, P. (2015) · Medicine · doi:10.1097/md.0000000000001990 · Cited by 39
Lin, Y., Chang, P., Chang, M., & Ni, Y. (2018) · Liver International · doi:10.1111/liv.13689 · Cited by 40
Inhibitory effect of blue honeysuckle extract on high-fat-diet-induced fatty liver in mice
Liu, M., Tan, J., He, Z., He, X., Hou, D., He, J., & Wu, S. (2018) · Animal nutrition · doi:10.1016/j.aninu.2018.06.001 · Cited by 39
Chan, D. C., Watts, G. F., Barrett, P. H. R., Mori, T. A., Beilin, L. J., & Redgrave, T. G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2283 · Cited by 40
Tessari, P., Kiwanuka, E., Barazzoni, R., Vettore, M., & Zanetti, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0288-2 · Cited by 39
Laughon, S. K., Catov, J. M., & Roberts, J. M. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.06.043 · Cited by 39
Association Between Insulin Resistance, Glucose Intolerance, and Hypertension in Pregnancy
Negrato, C. A., Jovanovič, L., Tambascia, M. A., Geloneze, B., Días, A., Calderon, I. D. M. P., & Rudge, M. V. C. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0043 · Cited by 39
Tai, T., Lu, J., Chen, C., et al. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780457 · Cited by 39
Minihane, A. M., Brady, L. M., Lovegrove, S. S., Lesauvage, S. V., Williams, C. M., & Lovegrove, J. A. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-0488-9 · Cited by 39
Fenofibrate Increases High Molecular Weight Adiponectin in Subjects with Hypertriglyceridemia
Oki, K., Koide, J., Nakanishi, S., Nakashima, R., & Yamane, K. (2007) · Endocrine Journal · doi:10.1507/endocrj.k06-172 · Cited by 39
Zhang, B., Kaneshi, T., Ohta, T., & Saku, K. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500192-jlr200 · Cited by 39
Effect of Weight Reduction on Metabolic Syndrome in Korean Obese Patients
Park, H. S., Sim, S. J., & Park, J. Y. (2004) · Journal of Korean Medical Science · doi:10.3346/jkms.2004.19.2.202 · Cited by 39
Muscle Fiber Composition and Capillary Density in Turner Syndrome
Gravholt, C. H., Nyholm, B., Saltin, B., Schmitz, O., & Christiansen, J. S. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1668 · Cited by 39
Chan, J. C. N. (2000) · QJM · doi:10.1093/qjmed/93.3.183 · Cited by 39
Insulin resistance and triglyceride/HDLc index are associated with coronary artery disease
Bertoluci, M. C., de Quadros, A. S., Sarmento‐Leite, R., & Schaan, B. D. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-11 · Cited by 40
Modeling Approaches to Type 2 Diabetes
Kansal, A. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504322783396 · Cited by 46
Prevalencia del síndrome metabólico entre pacientes con cardiopatía isquémica
Mijares, A. H., Fortuny, C. R., Izquierdo, E. S., Oliver, M. J. O., Triguero, M. L. M., Ariño, C. M., & Morales‐Suárez‐Varela, M. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)73907-4 · Cited by 39
Tufano, A., Marzo, P. F., Enrini, R., Morricone, L. F., Caviezel, F., & Ambrosi, B. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347497 · Cited by 39
Perticone, F., Ceravolo, R., Iacopino, S., Cloro, C., Ventura, G., Maio, R., Gulletta, E., Perrotti, N., & Mattioli, P. L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7117 · Cited by 39
Ahmed, S., Bennett, S. T., Huxtable, S. J., Todd, J. A., Matthews, D. R., & Gough, S. C. L. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00169.x · Cited by 38
Self-citationValidation of Insulin Resistance Indexes in a Stable Renal Transplant Population
Oterdoom, L. H., de Vries, A. P. J., van Son, W. J., van der Heide, J. J. H., Ploeg, R. J., Gansevoort, R. T., de Jong, P. E., Gans, R. O. B., & Bakker, S. J. L. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2424 · Cited by 39
Belcher, G., & Schernthaner, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01595.x · Cited by 39
Sunayama, S., Watanabe, Y., Ohmura, H., Sawano, M., Shimada, K., Mokuno, H., Daida, H., & Yamaguchi, H. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00138-0 · Cited by 39
Kabisch, S., Meyer, N. M. T., Honsek, C., Gerbracht, C., Dambeck, U., Kemper, M., Osterhoff, M. A., Birkenfeld, A. L., Arafat, A. M., Hjorth, M. F., et al. (2019) · Nutrients · doi:10.3390/nu11102385 · Cited by 38
“0.1 ± 0.5 −0.0 ± 0.4 −0.1 ± 0.4 0.2 ± 0.6 * n.s. † < 0.01 † < 0.05 n.s. Fasting Insulin (mU/L) −1.2 ± 3.2 −0.4 ± 4.3 −1.8 ± 3.6 ** 1.8 ± 5.2 * n.s. n.s. n.s. n.s. Fasting C-Peptide (µg/L) 0.1 ± 1.0 0.4 ± 1.3 0.1 ± 1.4 0.4 ± 1.6 n.s. n.s. n.s. n.s. HOMA-IR −0.3 ± 0.9 −0.1 ± 1.2 −0.6 ± 1.2 ** −0.6 ± 1.5 * n.s. n.s. n.s.…”
MethodInfluentialAnalysis of Insulin Sensitivity in Adipose Tissue of Patients with Primary Aldosteronism
Urbanet, R., Pilon, C., Calcagno, A., Peschechera, A., Hubert, E.-L., Giacchetti, G., Gomez-Sanchez, C., Mulatero, P., Toffanin, M., Sonino, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0097 · Cited by 38
Tao, T., Wu, P., Wang, Y., & Liu, W. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0243-5 · Cited by 38
Bajaj, H., Ye, C., Hanley, A. J., Connelly, P. W., Sermer, M., Zinman, B., & Retnakaran, R. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00403.2016 · Cited by 33
Kinsey, A. W., Eddy, W. R., Madzima, T. A., Panton, L. B., Arciero, P. J., Kim, J.-S., & Ormsbee, M. J. (2014) · British Journal of Nutrition · doi:10.1017/s0007114514001068 · Cited by 38
Igarashi, Y., Akazawa, N., & Maeda, S. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.45864 · Cited by 38
Exercise training at maximal fat oxidation intensity for older women with type 2 diabetes
Tan, S., Du, P., Zhao, W., Pang, J., & Wang, J. (2018) · International Journal of Sports Medicine · doi:10.1055/a-0573-1509 · Cited by 39
Preferential Stimulation of Abdominal Subcutaneous Lipolysis after Prednisolone Exposure in Humans
Gravholt, C. H., Dall, R., Christiansen, J. S., Møller, N., & Schmitz, O. (2002) · Obesity Research · doi:10.1038/oby.2002.105 · Cited by 38
Ott, R., Melchior, K., Stupin, J. H., Ziska, T., Schellong, K., Henrich, W., Rancourt, R. C., & Plagemann, A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01659 · Cited by 41
Ogawa, E., Furusyo, N., Murata, M., Ikezaki, H., Ihara, T., Hayashi, T., Toyoda, K., Taniai, H., Okada, K., Kainuma, M., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.027 · Cited by 38
Role of epigenomic mechanisms in the onset and management of insulin resistance
Izquierdo, A. G., & Crujeiras, A. B. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09485-0 · Cited by 39
Yang, X., Zhang, S., Dong, Z., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00127 · Cited by 38
Lin, H., Liu, M., Zhong, D., Ng, E. H. Y., Liu, J., Li, J., Shi, Y., Zhang, C., Wen, X., Mai, Z., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.709674 · Cited by 42
Masouleh, S. S., Bagheri, R., Ashtary‐Larky, D., Cheraghloo, N., Wong, A., Bilesvar, O. Y., Suzuki, K., & Siahkouhian, M. (2021) · Nutrients · doi:10.3390/nu13113958 · Cited by 41
Wen, Y., Chen, C., Kong, X., Xia, Z., Kong, W., Si, K., Han, P., Liu, W. V., & Li, X. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109860 · Cited by 40
Measures of Maternal Metabolic Health as Predictors of Severely Low Milk Production
Nommsen‐Rivers, L. A., Wagner, E. A., Roznowski, D. M., et al. (2022) · Breastfeeding Medicine · doi:10.1089/bfm.2021.0292 · Cited by 38
Mirza, I., Mohamed, A., Deen, H., Balaji, S., Elsabbahi, D., Munasser, A., Naquiallah, D., Abdulbaseer, U., Hassan, C., Masrur, M. A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214377 · Cited by 38
Triglyceride-glucose index and the incidence of stroke: A meta-analysis of cohort studies
Liao, C., Xu, H., Jin, T., Xu, K., Xu, Z., Zhu, L., & Liu, M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1033385 · Cited by 40
Leija, R. G., Curl, C. C., Arevalo, J. A., Osmond, A. D., Duong, J. J., Huie, M. J., Masharani, U. B., & Brooks, G. A. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00993-1 · Cited by 52
Hamasaki, H., Noda, M., Moriyama, S., Yoshikawa, R., Katsuyama, H., Sako, A., Mishima, S., Kakei, M., Ezaki, O., & Yanai, H. (2015) · Journal of Diabetes Research · doi:10.1155/2015/526201 · Cited by 40
Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery
de Weijer, B. A., Aarts, E. O., Janssen, I. M. C., Berends, F. J., van de Laar, A. W. J. M., Kaasjager, K. A. H., Ackermans, M. T., Fliers, E., & Serlie, M. J. M. (2013) · Obesity · doi:10.1002/oby.20220 · Cited by 37
Long, M., Zhou, J., Li, D., Lü, Z., Xu, Z., & Zhou, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126714 · Cited by 37
Chen, J.-H., Ouyang, C., Ding, Q., Song, J., Cao, W., & Mao, L. (2015) · Nutrients · doi:10.3390/nu7064724 · Cited by 43
Duarte, S. M. B., Faintuch, J., Stefano, J. T., de Oliveira, M. B. S., Mazo, D. F. D. C., Rabelo, F., Vanni, D. S., Nogueira, M. A., Carrilho, F. J., & de Oliveira, C. P. M. S. (2014) · PubMed · doi:10.3305/nh.2014.29.1.7068 · Cited by 39
Vrany, E. A., Berntson, J., Khambaty, T., & Stewart, J. C. (2015) · Annals of Behavioral Medicine · doi:10.1007/s12160-015-9725-0 · Cited by 38
Vila, M., Ruiz, O. L. C., Belmonte, M., Riesco, M., Barceló, A., Pérez, G., Moreiro, J., & Salinas, R. (2009) · Obesity Surgery · doi:10.1007/s11695-008-9790-6 · Cited by 38
Maghbooli, Z., Hossein‐Nezhad, A., Mirzaei, K., Karimi, F., Besharati, A., Omidfar, K., & Larijani, B. A. (2009) · Reproductive Sciences · doi:10.1177/1933719109351097 · Cited by 39
Takiguchi, S., Ayaori, M., Uto‐Kondo, H., Iizuka, M., Sasaki, M., Komatsu, T., Takase, B., Adachi, T., Ohsuzu, F., & Ikewaki, K. (2011) · Hypertension Research · doi:10.1038/hr.2011.11 · Cited by 38
Onat, A., Can, G., Çiçek, G., Ayhan, E., Doğan, Y., & Kaya, H. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0313-x · Cited by 38
Li, D., Xu, T., Takase, H., Tokimitsu, I., Zhang, P., Wang, Q., Yu, X., & Zhang, A. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.01.009 · Cited by 38
Takahashi, K., Mizuta, T., Eguchi, Y., Kawaguchi, Y., Kuwashiro, T., Oeda, S., Isoda, H., Oza, N., Iwane, S., Izumi, K., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0381-2 · Cited by 39
Schreuder, T. H. A., GREEN, D. J., Nyakayiru, J., Hopman, M. T. E., & Thijssen, D. H. J. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-3006-7 · Cited by 38
Smoking, inflammatory patterns and postprandial hypertriglyceridemia
Kabagambe, E. K., Ordovás, J. M., Tsai, M. Y., Borecki, I. B., Hopkins, P. N., Glasser, S. P., & Arnett, D. K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.005 · Cited by 38
Vitamin D, osteocalcin, and risk for adiposity as comorbidities in middle school children
Boucher‐Berry, C., Speiser, P., Carey, D. E., Shelov, S. P., Accacha, S. D., Fennoy, I., Rapaport, R., Espinal, Y., & ROSENBAUM, M. S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.550 · Cited by 38
Regional Distribution and Metabolic Effect of PCSK9 insLEU and R46L Gene Mutations and apoE Genotype
Awan, Z. A., DELVIN, E. E., Levy, E. H., Genest, J. J., Davignon, J., Seidah, N. G., & Baass, A. W. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.03.004 · Cited by 41
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
